Special symposia

12.15 – 13.15, Hall: Amazon

Special symposium
Funded and organised by BMS Pfizer

The evolving role of NOACs in the management of VTE

Chair: Prof. Menno Huisman (The Netherlands)

  • Initial management of VTE in 2016: current recommendations
    Dr Ander Cohen (United Kingdom)
  • Duration of treatment in VTE – role of NOACs
    Prof. Menno Huisman (The Netherlands)
  • Outstanding challenges in VTE management
    Prof. David Jimenez (Spain)
  • Q&A


12.15 – 13.15, Hall: Yangtze 1&2

Special symposium CSL Behring

Transforming the treatment of haemophilia B

Chair: Michiel Coppens (The Netherlands)

  • Introducing a new treatment for haemophilia B
    Michiel Coppens (The Netherlands)
  • The revolution in haemophilia B
    Alex Veldman (Germany)
  • Achieving a new standard of care
    Claude Négrier (France)
  • Question and answers
  • Summary and close
    Michiel Coppens (The Netherlands)